Skip to main content
Signal8
Xinos Jaime profile photo

Jaime Xinos

CIK: 0002041627

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)1 (16.7%)

Position reduction

Option Exercises (M)1 (16.7%)

Derivative conversions

Awards (A)4 (66.7%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

ACHIEVE LIFE SCIENCES, INC. logo
ACHV

ACHIEVE LIFE SCIENCES, INC.

Officer

Discretionary Trading P&L

Holdings

Transaction History (6 total)

  • ACHIEVE LIFE SCIENCES, INC. logo
    ACHV

    ACHIEVE LIFE SCIENCES, INC.

    Jan 28, 2026
    Award(A)

    Stock Option (right to buy)

    Direct
    180K shares-
  • ACHIEVE LIFE SCIENCES, INC. logo
    ACHV

    ACHIEVE LIFE SCIENCES, INC.

    Sep 4, 2025
    Exercise(M)
    Direct
    69K shares-
  • ACHIEVE LIFE SCIENCES, INC. logo
    ACHV

    ACHIEVE LIFE SCIENCES, INC.

    Sep 4, 2025
    Sale(S)
    Direct
    20.9K shares at avg. $2.77$58K
  • ACHIEVE LIFE SCIENCES, INC. logo
    ACHV

    ACHIEVE LIFE SCIENCES, INC.

    Jan 28, 2025
    Award(A)

    Performance Restricted Stock Unit (PRSU)

    Direct
    100K shares-
  • ACHIEVE LIFE SCIENCES, INC. logo
    ACHV

    ACHIEVE LIFE SCIENCES, INC.

    Jan 13, 2025
    Award(A)

    Stock Option (right to buy)

    Direct
    20K shares-
  • ACHIEVE LIFE SCIENCES, INC. logo
    ACHV

    ACHIEVE LIFE SCIENCES, INC.

    Dec 6, 2024
    Award(A)

    Stock Option (right to buy)

    Direct
    30K shares-

1-6 of 6

About Xinos Jaime

Xinos Jaime (SEC CIK 0002041627) files insider reports with the SEC as Chief Commercial Officer of ACHIEVE LIFE SCIENCES, INC. (ACHV).

Signal8 holds 6 ownership filings by Xinos Jaime (1 Form 3, 5 Form 4), filed between Oct 25, 2024 and Jan 30, 2026. Those filings report 6 transactions, from Dec 6, 2024 to Jan 28, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Xinos Jaime's filings is in BOTHELL, WA.

Recent filings by Xinos Jaime

  • Jan 28, 2026: Grant or award of ACHV derivative securities (Form 4, code A).
  • Sep 4, 2025: Option exercise of ACHV shares (Form 4, code M).
  • Sep 4, 2025: Open-market sale of ACHV shares (Form 4, code S).
  • Jan 28, 2025: Grant or award of ACHV derivative securities (Form 4, code A).
  • Jan 13, 2025: Grant or award of ACHV derivative securities (Form 4, code A).

Other insiders filing for ACHIEVE LIFE SCIENCES, INC. (ACHV)

How to read Form 4 transaction codes